A Pioneering Investigation Into Peak-Experiences
The overarching mission of this study is to improve our understanding of how mental, physical and environmental variables impact peak-experiences.
Simply put this means looking at how a wide span of variables (music, people, surroundings, substances etc) relate to “good” and “bad” psychedelic experiences and powerful flow states.
An improved understanding of these variables will lead to:
1. An increase in the safety, reliability, and quality of the psychedelic experience
2. A better understanding of how individuals can break into a flow state more consistently and easily
Mental, physical and environmental variables have never been tested in this way before. Our research will be the first study in history that examines the impact of external variables on psychedelic experiences and flow states. Our mission is to pave the way for future experimental research and a rigorous understanding of these variables.
Taking part in the study involves answering questions based on at least one experience you’ve had that falls into one of the four categories below. To participate you need to have had one of the following four experiences to be involved in the study:
If you don’t qualify––no worries. You can still contribute to the research by sharing this page on social media or via email. This would go a long way!
By investing 15 minutes in the survey you will:
Nutt is a neuropsychopharmacologist specializing in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Up until 2009 he was a professor at the University of Bristol heading their Psychopharmacology Unit. Nutt was also a member of the Committee on Safety of Medicines and was President of the European College of Neuropsychopharmacology.
His book Drugs Without the Hot Air won the Transmission Prize for Communicating Science in 2014.
Mendel is a postdoctoral neuroscientist at Imperial College London. His research interests include the function of music in psychedelic therapy and the development of accessible psychotherapeutic tools that can be used in conjunction with psychedelics. He is also the founder of Wavepaths, a venture that unifies immersive art, psychotherapy and intelligent technologies into a new category of therapeutic tools and spaces.
Steven is a New York Times bestselling author, an award-winning journalist and one of the world’s leading experts on high performance. He is the author of eight bestsellers, including Stealing Fire, The Rise of Superman, Bold and Abundance. His writing has been translated into over 40 languages and appeared in over 100 publications, including The New York Times, Atlantic Monthly, Wall Street Journal, Forbes, Wired and TIME.
De Wied is a masters student at Utrecht University. His research has focused primarily on internal and external non-drug factors and how these interact with the psychedelic experience. After completing a degree in Cognitive Neuroscience, his desire to be more directly involved in the therapeutic process inspired him to continue studying with a masters in Clinical Psychology.
Rian holds a BA (Hons) in Philosophy, Politics and Economics from Trinity College Dublin and has recently enrolled in an MSc in Applied Neuroscience at King’s College London. He plans to continue studying the neuropsychology that underscores peak-performance on to the PhD level while simultaneously working in a consulting capacity at the Flow Genome Project.
Robin Heads the Psychedelic Research Group within the Centre for Psychiatry at Imperial College London. He has over 50 published papers in peer-reviewed scientific journals; two of which were ranked in the top 100 most impactful academic articles of 2016. Robin’s research has featured in major national and international media and he has given a popular TEDx talk.
The Psychedelic Research Group at Imperial focuses on two main research areas: 1) the action of psychedelic drugs in the brain, and 2) their clinical utility, e.g. as aides to psychotherapy, with a particular focus on depression.
For news about our group's latest research and public presentations etc please see: http://psychedelicscience.org.uk
If you plan to take a psychedelic in the near future, please see this survey: https://psychedelicsurvey.com
The Flow Genome Project is an international organization dedicated to the research and training of ultimate human performance. Since the organizations conception in 2011, it has gone on to become the leading voice of evidence-based peak performance in the world, counting award-winning academics, legendary professional athletes, special operations commanders, and Fortune 500 leaders among the hundreds of thousands of people in its global community.